Chemical Compound

Paritaprevir

CAS Registry Number 1216941-48-8
Paritaprevir chemical structure
Primary Record

Paritaprevir

In stock
9,211 g
Purity
98.4 %
CAS
1216941-48-8

Compound Identifiers & Properties

CAS
1216941-48-8
PubChem CID
45110509
SMILES
CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8
Canonical SMILES
Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1

Names & Synonyms

  • Paritaprevir
  • Veruprevir
  • Veruprevir anhydrous
  • empty
  • paritapravir
  • paritaprevirum
  • ABT-450
  • 1216941-48-8
  • Veruprevir [INN]
  • Paritaprevir [USAN]
  • Paritaprevir(ABT-450)
  • Paritaprevir dihydrate
  • ABT450
  • Paritaprevir [USAN:INN]
  • RefChem:170090
  • OU2YM37K86
  • PARITAPREVIR [MI]
  • UNII-OU2YM37K86
  • PARITAPREVIR [INN]
  • ABT 450
  • Paritaprevir (ABT-450)
  • PARITAPREVIR [VANDF]
  • veruprevir (deprecated INN)
  • PARITAPREVIR [WHO-DD]
  • ATB450
  • DTXSID601027922
  • orb1304404
  • orb1305953
  • SCHEMBL3069964
  • CHEMBL3391662
  • SCHEMBL29359149
  • C40H43N7O7S
  • CHEBI:85188
  • GTPL11273
  • AMY6938
  • DTXCID501513483
  • GLXC-10645
  • PARITAPREVIR [ORANGE BOOK]
  • VIEKIRAX COMPONENT PARITAPREVIR
  • EX-A2278
  • Paritaprevir(Veruprevir ABT-450)?
  • C40-H43-N7-O7-S
  • EBC-27456
  • MFCD28411394
  • s5404
  • AKOS025396424
  • ZINC197964623
  • CCG-270449
  • CS-5051
  • DB09297
  • NCGC00509859-02
  • 1221573-85-8
  • AC-33061
  • AP178043
  • AS-75348
  • DA-66492
  • HY-12594
  • J3.361.353I
  • A856320
  • A857160
  • EN300-21959124
  • (2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-(5-methylpyrazin-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide
  • BRD-K89920762-001-01-4
  • Viekirax (ombitasvir + paritaprevir + ritonavir; EU)
  • (1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
  • (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide
  • Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide, N-(cyclopropylsulfonyl)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-6-[[(5-methyl-2-pyrazinyl)carbonyl]amino]-5,16-dioxo-2-(6-phenanthridinyloxy)-, (2R,6S,12Z,13aS,14aR,16aS)-
  • 2-Propenoic acid,3-[4-(dimethylamino)phenyl]-,butyl ester
  • B0084-474400
  • (2R,6S,13aS,14aR,16aS,Z)-N-(Cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
  • (1S,4R,6S,7Z,14S,18R)-N-(cyclopropanesulfonyl)-14-(5-methylpyrazine-2-amido)-2,15-dioxo-18-(phenanthridin-6-yloxy)-3,16-diazatricyclo[14.3.0.0,4,6]nonadec-7-ene-4-carboxamide
  • (1S,4R,6S,7Z,14S,18R)-N-(cyclopropanesulfonyl)-14-(5-methylpyrazine-2-amido)-2,15-dioxo-18-(phenanthridin-6-yloxy)-3,16-diazatricyclo[14.3.0.0?,?]nonadec-7-ene-4-carboxamide
  • (1S,4R,6S,7Z,14S,18R)-N-(cyclopropanesulfonyl)-14-(5-methylpyrazine-2-amido)-2,15-dioxo-18-(phenanthridin-6-yloxy)-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
  • (1S,4R,6S,7Z,14S,18R)-N-(Cyclopropylsulfonyl)-14-[(5-methyl-2-pyrazinyl)carbonylamino]-2,15-dioxo-18-[(phenanthridin-6-yl)oxy]-3,16-diazatricyclo[14.3.0.04,6]nonadeca-7-ene-4-carboxamide
  • (1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-((5-methylpyrazine-2-carbonyl)amino)-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo(14.3.0.04,6)nonadec-7-ene-4-carboxamide
  • (2R,6S,12Z,13aR,14aR,16aS)-N-(cyclopropanesulfonyl)-6-[(5-methylpyrazine-2-carbonyl)amino]-5,16-dioxo-2-[(phenanthridin-6-yl)oxy]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
  • (2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-(((5-methyl-2-pyrazinyl)carbonyl)amino)-5,16-dioxo-2-(6-phenanthridinyloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa(e)pyrrolo (1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide
  • (2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-{[(5-methylpyrazin-2-yl)carbonyl]amino}-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[E]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
  • Veruprevir|||ABT 450|||(2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide